Greenstreet Yvonne
SEC CIK 1446125 · EDGAR
BoughtSold
Most active insiders at ALNY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Greenstreet Yvonne | CEO, Dir | — | $24.46M |
| 2 | Fitzgerald Kevin Joseph | CSO, EVP, Head of Research | — | $10.74M |
| 3 | Garg Pushkal | EVP Chief R, D | — | $8.12M |
| 4 | Poulton Jeffrey V. | EVP, CFO | — | $4.95M |
| 5 | Tanguler Tolga | EVP, Chief Commercial Off | — | $3.06M |
| 6 | McLaughlin Melissa | CHRO | — | $1.27M |
| 7 | PYOTT DAVID E I | Dir | — | $1.15M |
| 8 | Reitan Colleen F | Dir | — | — |
| 9 | Sigal Charles Elliott | Dir | — | — |
| 10 | Arbuckle Stuart A | Dir | — | — |
Transactions 52
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-22 16:07 | 2026-09-19 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +107 | 95.8K | +0.1% | $0 | |
| M | 2026-03-06 | 2026-03-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale | $323.08 | -2,933 | 98.4K | -3% | -$947.6K |
| D | 2026-03-04 | 2026-03-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +13.8K | 105.4K | +15% | $0 |
| DM | 2026-03-04 | 2026-03-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale | $327.65 | -6,799 | 103.7K | -6% | -$2.23M |
| D | 2026-03-02 | 2026-02-27 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | M - OptEx | $0.00 | +5,921 | 91.6K | +7% | $0 |
| 2026-02-17 | 2026-02-13 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale | $310.08 | -6,958 | 85.7K | -8% | -$2.16M | |
| 2026-02-17 | 2026-02-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +14.2K | 92.6K | +18% | $0 | |
| M | 2026-01-14 | 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale | $362.86 | -9,577 | 81.7K | -10% | -$3.48M |
| 2026-01-14 | 2026-01-11 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +19.0K | 88.0K | +28% | $0 | |
| D | 2025-12-01 | 2025-11-26 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | F - Tax | $445.12 | -1,121 | 69.0K | -2% | -$499.0K |
| DM | 2025-12-01 | 2025-11-26 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | M - OptEx | $106.40 | +4,697 | 68.6K | +7% | +$499.8K |
| DM | 2025-11-14 | 2025-11-12+ | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale+OE | $452.75 | -25.6K | 74.2K | -26% | -$11.61M |
| DM | 2025-11-14 | 2025-11-12+ | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | M - OptEx | $117.18 | +25.6K | 81.1K | +46% | +$3.01M |
| M | 2025-10-03 | 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale | $452.05 | -8,924 | 69.9K | -11% | -$4.03M |
| M | 2025-10-03 | 2025-10-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +18.1K | 74.3K | +32% | $0 |
| M | 2025-08-19 | 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale | $453.27 | -6,979 | 62.4K | -10% | -$3.16M |
| 2025-08-19 | 2025-08-15 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +14.3K | 63.2K | +29% | $0 | |
| DM | 2025-06-03 | 2025-05-30+ | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale+OE | $305.00 | -50.9K | 55.1K | -48% | -$15.54M |
| DM | 2025-06-03 | 2025-05-30+ | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | M - OptEx | $118.56 | +50.9K | 61.0K | +505% | +$6.04M |
| 2025-05-19 | 2025-05-16 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | G - Gift | $0.00 | -8,376 | 48.9K | -15% | $0 | |
| 2025-05-06 | 2025-05-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | G - Gift | $0.00 | -41.3K | 57.3K | -42% | $0 | |
| DM | 2025-03-05 | 2025-03-03 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale | $243.79 | -3,877 | 99.5K | -4% | -$945.2K |
| D | 2025-03-05 | 2025-03-03 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +18.0K | 102.5K | +21% | $0 |
| D | 2025-03-03 | 2025-02-27 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | M - OptEx | $0.00 | +5,921 | 87.4K | +7% | $0 |
| DM | 2025-03-03 | 2025-02-28 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale+OE | $241.69 | -2,900 | 87.0K | -3% | -$700.9K |
| M | 2025-02-18 | 2025-02-14 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale | $255.17 | -1,213 | 81.6K | -1% | -$309.5K |
| 2025-02-18 | 2025-02-13 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +3,859 | 82.7K | +5% | $0 | |
| 2024-11-27 | 2024-11-25 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +10.7K | 84.1K | +15% | $0 | |
| M | 2024-11-27 | 2024-11-26 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale | $250.98 | -5,219 | 78.9K | -6% | -$1.31M |
| D | 2024-08-22 | 2024-08-20 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | M - OptEx | $85.00 | +15.0K | 88.4K | +20% | +$1.27M |
| D | 2024-08-22 | 2024-08-20 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale+OE | $280.00 | -15.0K | 73.4K | -17% | -$4.20M |
| D | 2024-08-02 | 2024-08-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale+OE | $270.00 | -15.1K | 73.4K | -17% | -$4.09M |
| D | 2024-08-02 | 2024-08-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | M - OptEx | $85.00 | +15.1K | 88.6K | +21% | +$1.29M |
| 2024-07-12 | 2024-07-11 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale | $261.00 | -7,093 | 73.4K | -9% | -$1.85M | |
| M | 2024-06-26 | 2024-06-25 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale | $230.99 | -8,301 | 88.5K | -9% | -$1.92M |
| 2024-06-26 | 2024-06-24 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +17.0K | 88.8K | +24% | $0 | |
| D | 2024-03-05 | 2024-03-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +23.8K | 71.9K | +49% | $0 |
| DM | 2024-02-29 | 2024-02-28 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale+OE | $155.31 | -2,932 | 48.1K | -6% | -$455.4K |
| D | 2024-02-29 | 2024-02-27 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | M - OptEx | $0.00 | +5,921 | 51.1K | +13% | $0 |
| M | 2024-02-20 | 2024-02-16 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale | $148.06 | -7,030 | 49.6K | -12% | -$1.04M |
| 2024-02-20 | 2024-02-15 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +17.0K | 52.2K | +48% | $0 | |
| M | 2023-08-07 | 2023-08-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale | $185.85 | -4,057 | 35.2K | -10% | -$754.0K |
| M | 2023-08-07 | 2023-08-03 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +8,941 | 35.4K | +34% | $0 |
| M | 2023-04-28 | 2023-04-27 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | S - Sale | $194.59 | -7,615 | 37.3K | -17% | -$1.48M |
| 2023-04-28 | 2023-04-26 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +17.0K | 37.9K | +81% | $0 | |
| M | 2022-08-05 | 2022-08-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | F - Tax | $191.68 | -6,002 | 21.2K | -22% | -$1.15M |
| M | 2022-08-05 | 2022-08-03 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +13.1K | 19.0K | +222% | $0 |
| D | 2022-06-08 | 2022-06-08 | PCRX | Pacira BioSciences, Inc. | Greenstreet Yvonne | Dir | A - Grant | $0.00 | +1,160 | 13.2K | +10% | $0 |
| 2021-12-23 | 2021-12-21 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Pres, COO | A - Grant | $0.00 | +5,417 | 16.4K | +49% | $0 | |
| M | 2021-12-23 | 2021-12-22 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Pres, COO | F - Tax | $189.01 | -2,538 | 13.9K | -15% | -$479.7K |
| D | 2021-08-09 | 2021-08-06 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Pres, COO | S - Sale+OE | $199.00 | -53.1K | 11.0K | -83% | -$10.56M |
| DM | 2021-08-09 | 2021-08-06 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Pres, COO | M - OptEx | $77.10 | +53.1K | 64.1K | +481% | +$4.09M |
Purchase Sale Sale after option exercise All abbreviations